(MedPage Today) — A meta-analysis of 27 randomized clinical trials found very low incidence of suicide-related adverse events among patients with diabetes or obesity on GLP-1 receptor agonists. (JAMA Psychiatry)
Installing safety nets on the…
Source link
New Data on GLP-1s and Suicide; Sleep and Conspiracy Theories; Xanax's Dark Side
